Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter].

International journal of chronic obstructive pulmonary disease·2026
Same author

Mucus Plug Formation is Associated with Eosinophilic Activation in Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2026
Same author

Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical Trials.

American journal of respiratory and critical care medicine·2026
Same author

Every Exacerbation Counts: Shifting the Dial for Future Exacerbation Risk.

American journal of respiratory and critical care medicine·2026
Same author

Small airways obstruction predicts cardiovascular disease incidence: a longitudinal study of UK Biobank.

ERJ open research·2026
Same author

A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians.

Journal of clinical medicine·2026

Video Experimental Relacionado

Updated: Jul 12, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Exacerbaciones de la EPOC: definiendo su causa y prevención.

Jadwiga A Wedzicha1, Terence A R Seemungal

  • 1Academic Unit of Respiratory Medicine, Royal Free and University College Medical School; University College London, UK. j.a.wedzicha@medsch.ucl.ac.uk

Lancet (London, England)
|September 4, 2007
PubMed
Resumen

El manejo de las exacerbaciones de la enfermedad pulmonar obstructiva crónica (EPOC) implica reducir el empeoramiento de los síntomas. Las estrategias futuras se centran en la combinación de terapias para mejorar la salud del paciente y reducir las hospitalizaciones.

Videos de Experimentos Relacionados

Last Updated: Jul 12, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Área de la Ciencia:

  • Medicina Pulmonar La medicina pulmonar es el tratamiento de las enfermedades pulmonares.
  • Investigación de Enfermedades Respiratorias Investigación de Enfermedades Respiratorias

Sus antecedentes:

  • Las exacerbaciones de la EPOC aumentan significativamente la morbilidad y la mortalidad.
  • Las exacerbaciones implican el aumento de las vías respiratorias y la inflamación sistémica, y la hiperinflación.
  • Las infecciones virales y bacterianas son los principales desencadenantes de las exacerbaciones de la EPOC.

Objetivo del estudio:

  • Revisar la comprensión actual de las exacerbaciones de la EPOC.
  • Discutir las intervenciones farmacológicas y no farmacológicas efectivas.
  • Explorar las direcciones futuras en la prevención de la exacerbación.

Principales métodos:

  • Revisión de la literatura sobre los desencadenantes de la exacerbación de la EPOC, la fisiopatología y el manejo.
  • Análisis de los tratamientos farmacológicos existentes (esteroides inhalados, broncodilatadores).
  • Evaluación de las terapias no farmacológicas (rehabilitación pulmonar, autogestión).

Principales resultados:

  • Las intervenciones farmacológicas reducen efectivamente la frecuencia y la gravedad de las exacerbaciones.
  • Las terapias no farmacológicas son prometedoras, pero requieren más ensayos controlados.
  • La susceptibilidad individual a las exacerbaciones influye en la progresión de la enfermedad y el estado de salud.

Conclusiones:

  • La gestión óptima requiere la combinación de enfoques farmacológicos y no farmacológicos.
  • La investigación futura debe centrarse en terapias personalizadas y combinadas para la EPOC.
  • El objetivo es mejorar el estado de salud y reducir la mortalidad asociada con las exacerbaciones de la EPOC.